PUBLISHER: The Business Research Company | PRODUCT CODE: 1947003
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947003
A Positron Emission Tomography (PET) scanner is a medical imaging device designed to generate detailed three-dimensional images of the internal structures of the human body. It utilizes a radioactive substance to assess and detect various chronic diseases by analyzing the functions of multiple organs. PET scanners are primarily employed for cancer detection and to evaluate the effectiveness of cancer treatment.
The main modalities of Positron Emission Tomography (PET) scanners include PET-CT (Positron Emission Tomography-Computed Tomography) and PET-MRI (Positron Emission Tomography-Magnetic Resonance Imaging). PET-CT refers to a scanner that combines functional data from PET scans with images of the body obtained through the detection of radiation from CT scans. Various types of detectors, such as gadolinium oxyorthosilicate, lutetium fine silicate, bismuth germanium oxide, and lutetium oxyorthosilicate, are utilized for applications in cardiology, neurology, oncology, orthopedics, urology, gastroenterology, and others. The end-users of these devices include hospitals, diagnostic centers, and other medical facilities.
Tariffs are impacting the positron emission tomography (PET) scanners market by increasing import and component costs for semiconductors, detector crystals, electronic assemblies, and imaging hardware used across pet-ct and pet-mri systems, resulting in higher manufacturing and procurement expenses for hospitals and diagnostic centers. The impact is more pronounced in North America, Europe, and Asia-Pacific regions that rely on cross-border sourcing of detector materials, gantry components, and radiopharmacy accessories supporting oncology and neurology imaging applications. These higher landed costs have contributed to pricing pressure and delayed capital equipment purchases in cost-sensitive facilities; however, tariffs are also encouraging localized assembly, regional component sourcing, and strategic manufacturing partnerships, creating selective positive outcomes for domestic imaging system producers.
The positron emission tomography (pet) scanners market research report is one of a series of new reports from The Business Research Company that provides positron emission tomography (pet) scanners market statistics, including positron emission tomography (pet) scanners industry global market size, regional shares, competitors with a positron emission tomography (pet) scanners market share, detailed positron emission tomography (pet) scanners market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (pet) scanners industry. This positron emission tomography (pet) scanners market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The positron emission tomography (pet) scanners market size has grown strongly in recent years. It will grow from $1.58 billion in 2025 to $1.66 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to rising incidence of cancer and chronic diseases requiring functional imaging, increasing hospital adoption of pet-ct systems for oncology diagnostics, early availability of gadolinium oxyorthosilicate and bismuth germanium oxide detector technologies, expansion of diagnostic imaging infrastructure in hospitals and specialty centers, growing clinical evidence supporting pet imaging in treatment planning.
The positron emission tomography (pet) scanners market size is expected to see strong growth in the next few years. It will grow to $2.12 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing demand for hybrid pet-mri and advanced pet-ct platforms, rising utilization of lutetium fine silicate and lutetium oxyorthosilicate detectors, growing application volumes in cardiology and neurology segments, expanding access to pet scanners in emerging healthcare markets, rising focus on precision imaging for personalized therapy assessment. Major trends in the forecast period include rising adoption of pet-ct and pet-mri imaging for advanced disease diagnosis and monitoring, increasing utilization of pet scanners in oncology for cancer detection and treatment evaluation, growing preference for hybrid and high-resolution pet imaging systems, expansion of pet imaging applications across cardiology neurology and gastroenterology, increasing deployment of pet scanners in hospitals and diagnostic centers.
The rising number of brain disorder cases is expected to drive the growth of the positron emission tomography (PET) scanners market in the coming years. Brain disorders refer to conditions that impair normal brain function due to illness, genetic factors, or traumatic injury. PET scans utilize a radioactive tracer to visualize both normal and abnormal metabolic activity in the brain. Positron emission tomography (PET) scanners help assess brain function, track disease progression, evaluate treatment response, and diagnose conditions that may not be detectable using other imaging techniques. For instance, in March 2024, according to the Alzheimer's Association, a US-based non-profit organization, approximately 6.9 million Americans aged 65 and older were living with Alzheimer's dementia as of 2024, a figure projected to rise to 13.8 million by 2060. Therefore, the growing prevalence of brain disorders is driving the growth of the positron emission tomography (PET) scanners market.
Major companies operating in the positron emission tomography (PET) scanner market are introducing innovative products by adopting advanced technologies such as Optiso Ultra Dynamic Range (UDR) detector technology to deliver reliable solutions to customers. Optiso Ultra Dynamic Range (UDR) detector technology represents a next-generation PET detector that integrates multiple technological advancements to ensure optimal performance across a broad range of count rates, thereby enhancing image quality and improving diagnostic accuracy, particularly for patients administered high-activity tracers. For instance, in June 2023, Siemens Healthineers AG, a Germany-based provider of healthcare solutions and services, launched the Biograph Vision X, a next-generation positron emission tomography/computed tomography (PET/CT) scanner. The system is built using Optiso Ultra Dynamic Range (UDR) detector technology and incorporates silicon photomultipliers (SiPMs), enabling the use of small 3.2 mm X 3.2 mm lutetium oxyorthosilicate (LSO) crystal elements to achieve higher spatial resolution compared to larger crystals, along with a time-of-flight (TOF) performance of 178 picoseconds. By fully coating these ultra-small LSO crystals with SiPMs, the scanner delivers an excellent 48-mm3 volumetric resolution and achieves a 20% performance improvement through TOF gain.
In February 2025, Cubresa, a Canada-based medical imaging company specializing in brain PET scanners, entered into a partnership with Siemens Healthineers for an undisclosed amount. Through this collaboration, Cubresa aims to develop and ensure full compatibility of its BrainPET(TM) scanner with Siemens MAGNETOM MRI systems across all field strengths, enabling simultaneous PET/MR imaging for advanced brain diagnostics. This integration is intended to enhance neuroimaging capabilities by combining high-resolution metabolic PET data with detailed structural and functional MRI information in a single session, supporting more accurate diagnosis and assessment of neurological disorders. Siemens Healthineers is a Germany-based medical technology company specializing in imaging, diagnostics, and healthcare solutions.
Major companies operating in the positron emission tomography (pet) scanners market are Hitachi Ltd., Canon Medical Systems USA Inc., Toshiba Corporation, Siemens Healthineers, Fujifilm Holdings Corporation, Koninklijke Philips N.V., GE HealthCare, CMR Naviscan Corporation, Shimadzu Corporation, Neusoft Medical Systems Co. Ltd., Mediso Medical Imaging Systems, Cubresa Inc., Oncovision, Mediso Ltd., MR Solutions Group Ltd., MinFound Medical Systems Co. Ltd, PETsys Electronics SA, Positron Corporation, RefleXion Medical, EdgePoint Medical
North America was the largest region in the positron emission tomography (PET) scanners market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (pet) scanners market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the positron emission tomography (pet) scanners market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The positron emission tomography (PET) scanners market consists of revenues earned by entities by providing services such as 3D imaging, detect cellular changes, diagnostic examination and nuclear medicine imaging. The market value includes the value of related goods sold by the service provider or included within the service offering. The positron emission tomography (PET) scanner market also includes sales of positron emission tomography tracers, portable PET scanners, and time-of-flight scanners. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Positron Emission Tomography (PET) Scanners Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses positron emission tomography (pet) scanners market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for positron emission tomography (pet) scanners ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The positron emission tomography (pet) scanners market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.